Uncategorised - European Medical Journal

Onc Now: Episode 7: Revolutionising Paediatric Radiation Oncology – Part 2

Ed Smith, pioneer in proton beam therapy, returns to discuss AI in radiation oncology and the future of the field. 

New Cream Offers Relief for Patients with Plaque Psoriasis

Tapinarof cream 1%, a novel nonsteroidal aryl hydrocarbon receptor agonist, has emerged as a promising solution for plaque psoriasis.

VISIBLE Study Drives Diversity in Psoriasis Research

In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.

Dynamic Model Improves Migrant Tuberculosis Detection

Tuberculosis (TB) remains a persistent health concern among migrants to low-TB-incidence countries, including Canada.

Reducing the CV Risks of Smoking

Smoking is a major risk factor for cardiovascular disease (CVD) and responsible for around 25% of all CVD-related deaths worldwide…

Estrogen-Progesterone Therapy Linked to Autoimmune Risks

A recent study exploring the impact of estrogen and progesterone analog supplementation on autoimmune conditions reveals a concerning association with several diseases.

Advances in Paediatric Oncology: Insights from SIOP 2024

Join our roundtable discussion led by Hannah Moir, featuring four experts in paediatric oncology: Kathy Pritchard-Jones, Nienke Streefkerk…

Key Predictors of Sudden Cardiac Events in Patients with Fontan Circulation

Cardiac MRI reveals key risk factors for sudden cardiac events in Fontan patients, potentially guiding better clinical care.

Intravenous Lidocaine Reduces Postoperative Discomfort in Spinal Surgery Patients

Intravenous lidocaine can significantly reduce catheter-related bladder discomfort and postoperative pain in patients undergoing complex lumbar spinal surgery.

Asthma Is a Significant Comorbidity in Children with Primary Ciliary Dyskinesia

A study reveals a strong link between primary ciliary dyskinesia and asthma in children.